ERIS Lifesciences Ltd.
|BSE: 540596||Sector: Health care|
|NSE: ERIS||ISIN Code: INE406M01024|
|BSE 15:40 | 23 Mar||783.35||
|NSE 15:42 | 23 Mar||785.05||
|Mkt Cap.(Rs cr)||10,771|
|Mkt Cap.(Rs cr)||10771.06|
ERIS Lifesciences Ltd. (ERIS) - Latest News & Headlines
9.39 am | 19 Mar 2018 | Business Standard
HEG zoomed 12% to Rs 3,515, also its new high, while Graphite India locked in upper circuit of 5% at Rs 814 on the NSE.
9.57 am | 6 Mar 2018 | Business Standard
Stock of the pharmaceutical company outperformed the market by gaining 12% in past five trading days, as compared to 1.3% decline in the S&P BSE Sense...
1.09 am | 22 Feb 2018 | Business Standard
Eris Lifesciences started new neuro-psychiatry and women healthcare divisions for Strides portfolio and a new nutrition division for UTH portfolio
12.41 pm | 1 Dec 2017 | Business Standard
PSP Projects, Eris Lifesciences, Tejas Networks and SIS have rallied by up to 125% against their issue price after making weak debut on the bourses du...
3.02 pm | 28 Nov 2017 | Business Standard
The stock rallied 11% to Rs 721, extending its 11% gain in past six trading sessions.
11.47 am | 20 Nov 2017 | Business Standard
Eris Lifesciences has surges 7% to Rs 628 in intra-day deal, while Strides Shasun was up 2% at Rs 805, after hitting high of Rs 822 on the BSE in intr...
10.46 pm | 18 Nov 2017 | Business Standard
Enters central nervous system (CNS) segment, breaks into top 25 domestic ranking
5.05 pm | 5 Oct 2017 | Business Standard
This is the company's first acquisition after being listed on the exchanges earlier this year